Filing Details
- Accession Number:
- 0001127602-13-009870
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-07 14:28:56
- Reporting Period:
- 2013-03-05
- Filing Date:
- 2013-03-07
- Accepted Time:
- 2013-03-07 14:28:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1355818 | L Judy Brown | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Executive Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-12-06 | 700 | $0.00 | 17,433 | No | 5 | G | Direct | |
Common Stock | Acquisiton | 2013-03-05 | 2,500 | $30.06 | 19,933 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-03-05 | 2,500 | $115.42 | 17,433 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option Right to Buy | Disposition | 2013-03-05 | 2,500 | $0.00 | 2,500 | $30.06 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
11,416 | 2019-08-25 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1sales plan adopted by the reporting person on December 7, 2012. This 10b5-1 sales plan will expire on the close of business December 31, 2013.
- The price in column 4 is a weighted average. The prices actually received ranged from $115.05 to $115.705. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Exercisable in 3 equal annual installments beginning 8/25/2010